Stocks

Gilead Sciences surprised investors with stronger-than-expected Q2 results, driven by a surge in its HIV portfolio. The biotech giant reported...

Apple investors breathed a sigh of relief as the tech giant secured an exemption from proposed 100% tariffs on semiconductor...

Dutch cloud computing firm Nebius, a former Yandex spin-off, has stunned markets with explosive quarterly growth, reporting a 625% revenue...

Eli Lilly is poised to capitalize on explosive growth in India for its diabetes and weight-loss drug Mounjaro, with sales...

Datadog's stock surged over 8% in pre-market trading after the cloud-monitoring company reported better-than-expected Q2 results, with earnings per share...

Danish biotech firm Genmab saw its shares jump over 5% to $22.70 after announcing groundbreaking Phase 3 trial results for...

Warner Bros. Discovery stunned analysts by reporting a net profit of $1.58 billion in Q2, a dramatic reversal from last...

Conocophillips delivered a paradoxical second-quarter performance, with record production volumes contrasting sharply with declining profits. The oil giant reported a...

Commerzbank reported its strongest quarterly performance in history, with operating profit surging 33% to €1.17 billion, surpassing analyst expectations of...

Freenet's shares tumbled 5.7% to a nine-month low after disappointing Q2 results, with revenue missing forecasts by 1.5% (€609M) and...